Current perspectives on recurrent pituitary adenoma: the role and timing of surgery vs adjuvant treatment

Hayhurst, C., Taylor, P.N. ORCID: https://orcid.org/0000-0002-3436-422X, Lansdown, A.J., Palaniappan, N., Rees, D.A. ORCID: https://orcid.org/0000-0002-1165-9092 and Davis, J.S. 2020. Current perspectives on recurrent pituitary adenoma: the role and timing of surgery vs adjuvant treatment. Clinical Endocrinology 92 (2) , pp. 89-97. 10.1111/cen.14127

PDF - Accepted Post-Print Version Download (431kB)

Abstract

The clinical course of pituitary adenoma can be highly variable. Aggressive pituitary tumours may require multimodal therapy with multiple operations. Even standard pituitary adenomas exhibit relatively high long‐term recurrence rates and delayed intervention is often required. The indications for revision surgery in the endoscopic era are expanding for both functioning and nonfunctioning tumours, including access to the cavernous sinus and intracranial compartments. Although revision surgery can be challenging, it has been demonstrated to be both safe and effective. The question of the use of early radiotherapy in pituitary adenoma remains controversial. Our increasing understanding of pituitary tumour biology facilitates individualized treatment and surveillance protocols, with early intervention in high‐risk adenoma subtypes. In this review, we discuss the treatment options for recurring pituitary tumours and focus on the role of revision surgery.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Wiley
ISSN:	0300-0664
Date of First Compliant Deposit:	14 November 2019
Date of Acceptance:	10 November 2019
Last Modified:	13 Nov 2023 20:46
URI:	https://orca.cardiff.ac.uk/id/eprint/126836

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item